Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Metabolic and Cardiovascular Pharmacology

Novartis Institute for Biomedical Research

Summit

NJ 07901

USA

Name/email consistency: high

Metabolic and Cardiovascular Pharmacology, Novartis Institute for Biomedical Research, Summit, NJ 07901, USA. 2001
Department of Metabolic and Cardiovascular Diseases and. Core Technologies, Novartis Institute of Biomedical Research, Novartis Pharmaceutical, Summit, USA. 2001
Joslin Diabetes Center, Boston, Massachusetts, USA. 1997

Differential effects of short and long duration insulinotropic agents on meal-related glucose excursions. de Souza, C.J., Russo, P., Lozito, R., Dunning, B.E. Diabetes. Obes. Metab (2001) [Pubmed]
Early insulin release effectively improves glucose tolerance: studies in two rodent models of type 2 diabetes mellitus. de Souza, C.J., Gagen, K., Chen, W., Dragonas, N. Diabetes. Obes. Metab (2001) [Pubmed]
Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans. de Souza, C.J., Burkey, B.F. Curr. Pharm. Des. (2001) [Pubmed]
Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. de Souza, C.J., Eckhardt, M., Gagen, K., Dong, M., Chen, W., Laurent, D., Burkey, B.F. Diabetes (2001) [Pubmed]
CL-316,243, a beta3-specific adrenoceptor agonist, enhances insulin-stimulated glucose disposal in nonobese rats. de Souza, C.J., Hirshman, M.F., Horton, E.S. Diabetes (1997) [Pubmed]